GW HENSSLER & ASSOCIATES LTD - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 762 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.

Quarter-by-quarter ownership
GW HENSSLER & ASSOCIATES LTD ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$24,124,058
+0.8%
236,835
-0.1%
1.65%
+4.8%
Q2 2023$23,933,677
-38.9%
237,178
-44.3%
1.57%
-39.6%
Q1 2023$39,181,762
+3.2%
425,889
+1.7%
2.60%
-2.4%
Q4 2022$37,983,338
+21.6%
418,688
+1.9%
2.67%
+14.1%
Q3 2022$31,227,000
-3.4%
410,831
+7.5%
2.34%
-2.6%
Q2 2022$32,317,000
+62.9%
382,308
+69.1%
2.40%
+99.1%
Q1 2022$19,842,000
+9.0%
226,121
+8.6%
1.20%
+3.8%
Q4 2021$18,207,000
+6.6%
208,154
-0.3%
1.16%
-2.0%
Q3 2021$17,082,000
-4.8%
208,878
+6.2%
1.18%
+0.4%
Q2 2021$17,940,000
+11.1%
196,627
+4.1%
1.18%
+2.2%
Q1 2021$16,153,000
-5.2%
188,963
+4.7%
1.16%
-11.2%
Q4 2020$17,036,000
+10.3%
180,405
+1.6%
1.30%
-0.7%
Q3 2020$15,446,000
+2.9%
177,625
+3.4%
1.31%
-0.7%
Q2 2020$15,009,000
+15.8%
171,851
+9.3%
1.32%
+0.5%
Q1 2020$12,962,000
+16.2%
157,206
+33.4%
1.31%
+42.3%
Q4 2019$11,159,000
+15.9%
117,852
+6.4%
0.92%
+7.7%
Q3 2019$9,625,000
-2.9%
110,762
+2.0%
0.86%
-4.5%
Q2 2019$9,911,000
+6.3%
108,539
+11.9%
0.90%
+4.9%
Q1 2019$9,326,000
+13.9%
97,000
+1.7%
0.86%
-2.2%
Q4 2018$8,186,000
+4.1%
95,402
+4.6%
0.87%
+22.2%
Q3 2018$7,860,000
+17.8%
91,222
+3.3%
0.72%
+9.3%
Q2 2018$6,670,000
-1.1%
88,297
+5.8%
0.65%
-3.5%
Q1 2018$6,745,000
-1.4%
83,430
+2.3%
0.68%
+5.9%
Q4 2017$6,844,000
+3.8%
81,515
+6.2%
0.64%
-3.2%
Q3 2017$6,591,000
+10.4%
76,769
+7.3%
0.66%
+6.3%
Q2 2017$5,972,000
+19.8%
71,546
+6.6%
0.62%
+15.6%
Q1 2017$4,984,000
+24.0%
67,108
+21.7%
0.54%
+20.9%
Q4 2016$4,018,000
-10.2%
55,162
-2.7%
0.44%
-13.1%
Q3 2016$4,475,000
-0.4%
56,672
+4.0%
0.51%
-1.2%
Q2 2016$4,495,000
+28.6%
54,479
+12.9%
0.52%
+26.3%
Q1 2016$3,495,000
-7.0%
48,251
+10.4%
0.41%
-7.9%
Q4 2015$3,760,000
-19.5%
43,700
-13.9%
0.44%
-17.0%
Q3 2015$4,668,000
-3.2%
50,779
+3.5%
0.54%
+2.3%
Q2 2015$4,823,000
+3.1%
49,041
+3.4%
0.52%
-3.1%
Q1 2015$4,677,000
+7.6%
47,426
+1.1%
0.54%
+11.1%
Q4 2014$4,348,000
-1.3%
46,920
+0.2%
0.49%
-8.8%
Q3 2014$4,407,000
+10.4%
46,814
+6.1%
0.53%
+10.3%
Q2 2014$3,993,000
+1.6%
44,107
-4.6%
0.48%
+5.0%
Q1 2014$3,931,000
-6.3%
46,240
-11.4%
0.46%
-6.1%
Q4 2013$4,196,000
+3.5%
52,206
-1.3%
0.49%
-6.1%
Q3 2013$4,056,000
+7.7%
52,873
-0.7%
0.52%
+1.0%
Q2 2013$3,766,00053,2600.52%
Other shareholders
NOVARTIS A G shareholders Q3 2013
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders